Sanyo Chemical’s Silk-Elastin Shows Promise in Wound Healing Clinical Trial Results Published in Scientific Reports — Seeking U.S. Partners for Market Entry —April 22, 2025
Sanyo Chemical Consecutively Selected for the FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative IndexAugust 30, 2024
Investigator Initiated Trial Confirms Safety of Silk-Elastin for Meniscus Injury－Multi-Center Collaborative Corporate Clinical Trial to Seek Approval for Meniscal Repair and Regeneration Medical Devices－August 30, 2024
Confirmation of High Safety and Efficacy of Artificial Protein Silk-Elastin® in Chronic Wound Healing－Innovative Material for Chronic Wound Healing Moves Toward to Regulatory Approval－August 30, 2024
Sanyo Chemical Signs MOU with Econic to Advance CO2-Based Polyols for Carbon NeutralityApril 23, 2024
